CHIMERIX INC. - COMMON STOCK

Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs

08 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Chimerix to Present at Wedbush PacGrow Healthcare Conference

02 8月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Chimerix to Report Second Quarter 2022 Financial Results and Provide an Operational Update on August 8, 2022

01 8月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada

24 6月 2022 09:06:16 条件 Nasdaq GlobeNewswire

Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement

23 6月 2022 08:15:16 条件 Nasdaq GlobeNewswire

Chimerix to Present at Jefferies Global Healthcare Conference

01 6月 2022 15:30:00 条件 Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright Global Investment Conference

17 5月 2022 15:15:00 条件 Nasdaq GlobeNewswire

Chimerix Reports First Quarter 2022 Financial Results and Provides Operational Update

16 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties

16 5月 2022 05:30:00 条件 Nasdaq GlobeNewswire

Chimerix to Participate in Maxim Group Panel Discussion

12 5月 2022 15:15:00 条件 Nasdaq GlobeNewswire

Chimerix to Report First Quarter 2022 Financial Results and Provide an Operational Update on May 16, 2022

09 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Chimerix to Present at Maxim Group 2022 Virtual Growth Conference

21 3月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Chimerix Reports Fourth Quarter and Year End 2021 Financial Results and Provides Operational Update

01 3月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Chimerix, in Collaboration with the Rapidly Emerging Antiviral Drug Development Initiative (READDI) at the University of North Carolina-Chapel Hill, Announces Late-Breaking Oral Presentation at International Conference on Antiviral Research

24 2月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Chimerix to Report Fourth Quarter and Year End 2021 Financial Results and Provide an Operational Update on March 1, 2022

22 2月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Chimerix to Present at B. Riley Virtual Oncology Conference

20 1月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research

18 1月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Chimerix to Present at Virtual H.C. Wainwright BioConnect 2022 Conference

03 1月 2022 15:45:00 条件 Nasdaq GlobeNewswire

Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual Meeting

19 11月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Chimerix to Present at Jefferies London Healthcare Conference

12 11月 2021 07:00:01 条件 Nasdaq GlobeNewswire